Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Marketed
Current status date:
2013-01-08
Original market date: See footnote 1
2013-01-08
Product name:
SEACALPHYX
DIN:
02386666
Product Monograph/Veterinary Labelling:
Date:
2014-07-16
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
SEAFORD PHARMACEUTICALS INC
UNIT 29
1530 Drew Road
Mississauga
Ontario
Canada
L5S 1W8
Class:
Human
Dosage form(s):
Solution
Route(s) of administration:
Intravenous
Number of active ingredient(s):
1
Schedule(s):
Ethical
American Hospital Formulary Service (AHFS): See footnote 3
92:12.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
V03AB06 THIOSULPHATE
Active ingredient group (AIG) number:See footnote5
0109248001
| Active ingredient(s) | Strength |
|---|---|
| SODIUM THIOSULFATE | 250 MG / ML |